Navi Officially Open’s Angel Round At Melbourne Angel Event

Navi CEO Alex Newton officially opened Navi’s Angel Round of funding earlier this week by presenting its vision at the investor community network, Melbourne Angels.

Navi is looking to raise $600k, which will go towards the development of the clinical prototype of the Neonav, a medical device that aims to significantly improve catheter placement in critically-ill pediatric patients. The Neonav is addressing a specific problem relating to high rates of misplacement of central line catheters in critically-ill newborn patients, with approximately 40% of these procedures being misplaced in the initial attempt, resulting in delays in essential drug delivery, increased patient X-ray exposure, and reduced hospital efficiencies.

Pictured: Navi CEO Alex Newton pitching at Melbourne Angels

Pictured: Navi CEO Alex Newton pitching at Melbourne Angels

“Melbourne Angels have been a huge support to home-grown startups in Australia, and we are privileged to be able to share our vision with them, and excited about the prospect of partnering with members of this incredible community.”

For investor communication, please send enquiries to info@navitechnologies.com

 

Q&A with Mubin Yousuf, Navi's CTO

Over 15 million babies are born premature globally each year, with many of them being born in developing nations. As a result, there are a large number of critically-ill newborns that have limited access to medical innovations compared to that of developed countries like Australia and the United States.

This lack of accessibility is at the heart of what drives the team at Navi, and this is particularly true for Navi Chief Technical Officer Mubin Yousuf; who is originally from Pakistan and has a unique and personal drive in helping newborns that need it most.
Mubin has recently returned from a trip to Pakistan, where he spent time speaking with doctors and hospitals in Karachi to better understand the problems developing nations like Pakistan face in intensive neonatal and paediatric care, and how companies like Navi can develop products to help give children brighter, happier futures.

Q: Who are you and what do you do?
MY:
 My name is Mubin and I have a master’s degree in biomedical engineering. I am currently a cofounder and Chief Technology Officer at Navi Medical Technologies; I am also working part-time as a research engineer at Murdoch Children’s Research Institute’s Cardiovascular Bioengineering Team.

Q: What is the current state of the health care system in Pakistan?
MY:
 Healthcare in Pakistan is divided into two big sectors, the government/public sector and the private sector. Each have their own inpatient and outpatient departments. The public sector receives funding from the government and offers patient care either as free or at very low cost whereas the private sector is relatively high in terms of cost to the patients. The public hospitals is do their best but the lack of is sufficient infrastructure to cater for Pakistan's growing population poses a real challenge.

Q: What are the current needs and problems facing paediatric and neonatal medicine in Pakistan?
MY:
 My experience visiting NICU’s [neonatal intensive care units] in Pakistan was very enlightening, especially in the public sector. I visited one of the largest public NICUs of Pakistan, and what was most surprising was that there was a 22 day waiting line for patients to get a standard Xray - a sobering reflection of how understaffed and over populated with patients some hospitals in Pakistan can be.

Q: As an engineer, what most excites you about developing the neoNAV?
MY:
 It would have to be utilising cutting-edge AI [artificial intelligence] in collaboration with neonatologists and electrophysiologists to develop a medical device that makes a big difference to premature babies. A dream come true!

Navi to present at MAP Entrepreneur Gala

Navi was honoured to be invited as a guest presenter at the Melbourne Accelerator Program (MAP) showcase event, the Melbourne Entrepreneur Gala, in August 2018.

The black-tie gala, which was attended by the “who’s who” of the entrepreneurship scene in Australia, is an event that focused on celebrating and connecting entrepreneurs with industry leaders across a number of different sectors.

Navi co-founder Wei Sue represented Navi at the event, and presented Navi’s work on the Neonav, which aims to improve catheter placement procedures in critically-ill newborns to achieve better patient outcomes.

Team Navi celebrating at the Melbourne Entrepreneurship Gala with University of Melbourne VC Glyn Davies. Pictured from left to right: Alex Newton, Brad Bergmann, Wei Sue, Mubin Yousuf, Shing Sheung, Glyn Davis, Prof. David Grayden

Team Navi celebrating at the Melbourne Entrepreneurship Gala with University of Melbourne VC Glyn Davies. Pictured from left to right: Alex Newton, Brad Bergmann, Wei Sue, Mubin Yousuf, Shing Sheung, Glyn Davis, Prof. David Grayden

Navi Wins First Prize at Start-Up Vic Pitch Night

Wei Sue (CFO) representing Navi’s win at Start Up Vic’s Pitch Night.

Wei Sue (CFO) representing Navi’s win at Start Up Vic’s Pitch Night.

Navi proudly announces Co-Founder Wei Sue’s first prize win at Start Up Vic's Pitch Night on 29th August 2017.

During the final round of the event, the top four finalists were selected to pitch their health technology startups to a panel of judges and a large crowd, held at the PwC building in Melbourne.

Navi won $150,000 worth of prizes and a wild card entry into MedTech’s Got Talent - Australia's largest start-up competition.

Aside from being the judges’ favourite, Navi also won the people’s choice award during the event. As a result, Navi will be featured in Start Up VIC's upcoming newsletter.

Navi COO Named in Forbes "30 Under 30"

 
20.png
 

Navi announces that our COO and Co-founder, Shing Sheung, has been named in the Forbes "30 Under 30" list for Healthcare & Science in the Asia/Pacific Region.

The nomination followed after Shing spent several months in the Texas Medical center in Houston - where he was a participant in the TMCx Innovation program. During his time in Houston, Shing engaged with clinical and industry leaders to further the develop the Neonav - Navi’s medical device which primarily aims to significantly improve catheter positioning and placement in neonates by providing clinicians with real-time feedback on catheter tip localisation. Navi ultimately hopes that the Neonav will help set a much-needed, new standard in neonatal care.

Shing Sheung, honoured by the acknowledgment, shared a few words regarding his relentless dedication to the development of the Neonav: "It's a real honour to be named alongside so many other inspiring individuals. Thank you to Forbes who recognises our work at Navi. As a team, we're absolutely determined to create medical innovations to help children everywhere live brighter, healthier futures."

 

Navi Honoured With Leadership Award From Melbourne Business School

The Melbourne Business School, in partnership with the University of Melbourne, has awarded the Navi team the "2018 Alumni Leadership Award" at the Leadership Dinner event in Melbourne, Australia.

The Melbourne Business School Dean, Professor Ian Harper, honoured Navi at the event in light of its work in developing the Neonav - a catheter tip confirmation device that will assist healthcare professionals to reduce the high misplacement rates of central line catheters in neonates. "The School would like to recognise [Navi] for the inspirational success of your pioneering endeavour in paediatric medical technology with the presentation of the Alumni award..."

Navi CEO Alex Newton accepting the Leadership Award at the MBS Leadership Dinner 2018

Navi CEO Alex Newton accepting the Leadership Award at the MBS Leadership Dinner 2018

Navi CEO Alex Newton graciously accepted the award on behalf of team Navi. He stated his thanks for the support and guidance the university continues to offer in Navis pursuit of improving the standard of neonatal care. "It takes a lot of work to transform an idea factory into a revenue-generating business - and I am thankful for the continued support of the alumni and faculty of the Melbourne Business School."

Navi was formed out of the 2016 Biodesign and Innovation course - a joint venture between the Melbourne Business School and University of Melbourne. The course was designed to bring together biomedical engineers, MBAs, and clinicians to help identify and solve an existing and current medical need. “It’s great to see things come full-circle in this way - and have our efforts acknowledged by mentors who helped us initiate the start of Navi. We’re very excited to see the trajectory Navi will continue to be heading on next.”

Navi CEO Presents at SXSW

Navi CEO Alex Newton was recently invited to pitch the Neonav to the Pediatric Impact Health challenge at the 2018 South by South West (SXSW) festival in Austin, Texas.

 

The event is sponsored and attended by representatives from the top 8 children's hospital in the US. Its main purpose is to provide an opportunity to bring together the most promising paediatric-focused start-ups from around the world to present their ideas and network with key leaders in the pediatric healthcare field.

 

"The opportunity to meet representatives from leading US children's hospitals and engage in extensive discussions on the challenges they face, as well as the benefits that we can offer them via the Neonav was incredible,” Alex noted.

 

Following the Impact Pediatric Health event, Navi was invited to present at an AusTrade-organized event at Australia House - a space focusing on showcasing new technologies being developed in Australia. “These kinds of events present such amazing opportunities for us,” Alex says. “As an Australian-based company with our sights set on the US market, any chance we get to interact and build our network in this key market is absolutely invaluable.”

Navi Joins Australia's Premier Medtech Accelerator

 
16.png
 

Navi proudly announces that it has been selected as one of six start-up companies to be accepted into the inaugural cohort of The Actuator Accelerator Program - Australia's largest medical device focused accelerator program.

The Actuator is engaged in close partnership with the Australian Government, Artesian, MTP Connect, and a range of industry partners (including Medtonic and Johnson & Johnson). The program will be providing Navi with initial seed funding along with an advanced mentorship program designed to accelerate the commercialisation pathway.

The 15-month program consists of a structured 12-month mentor-led development phase, followed by an intensive 3 month ‘investor road show’. “We are incredibly excited to be launching The Actuator—Australia’s National MedTech Accelerator,” says Dr Buzz Palmer, CEO of The Actuator. “Our mission is to support our homegrown talent within their local innovation ecosystems in order to build incredible successes. We are eager to witness how game-changing ideas will emerge and develop right out of Australia.”

One of the primary purposes of the Actuator program is to get start-up companies ‘investment-ready’ and assist with easier access to funding through partners such as venture capital partners Artesian. Navi CEO Alex Newton states he is excited about the opportunities that the Actuator program offers: "Our partnership with the Actuator and Artesian means will accelerate our product development activities and enhance success for our future capital raising rounds."

The Actuator is engaged in close partnership with the Australian Government, Artesian, MTP Connect, and a range of industry partners (including Medtronic and Johnson & Johnson). The program will be providing Navi with initial seed funding along with an advanced mentorship program designed to accelerate the commercialisation pathway.

The 15-month program consists of a structured 12-month mentor-led development phase, followed by an intensive 3 month ‘investor road show’. “We are incredibly excited to be launching The Actuator—Australia’s National MedTech Accelerator,” says Dr Buzz Palmer, CEO of The Actuator. “Our mission is to support our homegrown talent within their local innovation ecosystems in order to build incredible successes. We are eager to witness how game-changing ideas will emerge and develop right out of Australia.”

One of the primary purposes of the Actuator program is to get start-up companies ‘investment-ready’ and assist with easier access to funding through partners such as venture capital partners Artesian. Navi CEO Alex Newton states he is excited about the opportunities that the Actuator program offers: "Our partnership with the Actuator and Artesian means will accelerate our product development activities and enhance success for our future capital raising rounds."

 

Navi Wins Top Cash Prize at Medtech's Got Talent National Finals Gala

Pictured from left to right: David Grayden, Shing Sheung (COO), Wei Sue (CFO), Alex Newton (CEO), Mubin Yousuf (CTO)

Pictured from left to right: David Grayden, Shing Sheung (COO), Wei Sue (CFO), Alex Newton (CEO), Mubin Yousuf (CTO)

Last week, Navi was awarded a top prize of $20,000 in cash at Medtech's Got Talent National's Final Gala. Additionally, Navi was also voted as the "People's Choice" start-up company - and consequently received a further $1,000 cash prize.

The winning pitch, delivered by Navi Co-founder Wei Sue, was presented at the National Finals as part of Australia's largest medical device accelerator program.

Eighteen of the best medical device startups from around Australia were selected to present at the black-tie event in Melbourne, Australia, in front of a panel of judges. Only the top 5 pitches at the event were awarded the $20,000 cash prize and granted entry into the next stage of the accelerator program.

Wei Sue stated she was thrilled with the win and “grateful for those that had helped Navi over the past few months.”

 "Receiving the EY Award at the Medtech's Got Talent 2017 Gala Night greatly validates the progress we've made in the last few months. Special thanks go to our mentors at D+I, University of Melbourne and Melbourne Business School - as well as the overwhelming support we've received from others in the community.”

Following this win, Navi is now eligible to commence an intensive mentoring and training program that begins December 2017 which offers assistance in raising seed investment.

Navi Secures $20k Cash Prize at Healthtech Innovation Challenge

Left to right: Wei Sue (CFO), Alex Newton (CEO), Christiane Theda (CMO, Medical)

Left to right: Wei Sue (CFO), Alex Newton (CEO), Christiane Theda (CMO, Medical)

Navi CEO Alex Newton delivered a winning pitch at the Graeme Clark Institute's HealthTech Innovation Challenge.

Navi was selected to present with seven other finalists to a panel comprising of representatives from hospital, academic, industry and government organisations. The judges awarded a $20,000 cash prize to Navi and other participants who demonstrated innovative inter-disciplinary research - specifically those showcasing significant potential for future funding by granting bodies and/or industry.

"Winning this award is further validation that our medical device, the Neonav, is addressing an important but often overlooked medical problem in the neonatal population,” Alex Newton stated after receiving the award. He continued, “Securing the $20,000 cash prize will go towards our upcoming research into neonatal vascular access."